In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity - PubMed (original) (raw)
. 2013 Jan 30;441(1-2):728-35.
doi: 10.1016/j.ijpharm.2012.10.021. Epub 2012 Oct 23.
Affiliations
- PMID: 23089583
- DOI: 10.1016/j.ijpharm.2012.10.021
In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity
Yancai Wang et al. Int J Pharm. 2013.
Abstract
The present study aims to evaluate the anticancer activity of puerarin nanosuspensions in human colon cancer HT-29 cell line in vitro and in vivo. Puerarin nanosuspensions were prepared by the high-pressure homogenization (HPH) technique. The HT-29 cells were incubated with increasing concentrations of puerarin solution and nanosuspensions for indicated times. MTT evaluated cellular viability and investigated the effect of puerarin on cell proliferation of HT-29. Annexin V-FITC/PI staining method was conducted to determine the influences of the puerarin nanosuspensions on cell cycle and apoptosis. The in vivo anticancer activity of the puerarin nanosuspensions was observed in HT-29 cancer bearing mice. The puerarin nanosuspensions were well re-dispersed in aqueous media a mean diameter about 400-500 nm. Cytotoxicity assay, observation of morphological changes and early apoptosis revealed that the puerarin nanosuspensions could significantly enhance the in vitro anti-proliferation against HT-29 cells compared to the puerarin free solution. The prepared puerarin nanosuspensions in vivo evaluation showed higher anticancer efficacy and lower toxicity compared to the free solution, as shown by changes in tumor volumes, body weights, and survival rates. Based on these data, the potential of the puerarin nanosuspensions to serve as a cancer chemotherapeutic agent for colon cancer could be suggested.
Copyright © 2012 Elsevier B.V. All rights reserved.
Comment in
- Anti-neoplastic effects of puerarin in systemic malignancies besides colon carcinomas.
Kapoor S. Kapoor S. Int J Pharm. 2013 Feb 25;443(1-2):306. doi: 10.1016/j.ijpharm.2012.12.047. Epub 2013 Jan 5. Int J Pharm. 2013. PMID: 23299086 No abstract available.
Similar articles
- Induction of apoptosis by puerarin in colon cancer HT-29 cells.
Yu Z, Li W. Yu Z, et al. Cancer Lett. 2006 Jul 8;238(1):53-60. doi: 10.1016/j.canlet.2005.06.022. Epub 2005 Aug 1. Cancer Lett. 2006. PMID: 16055262 - Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice.
Lou H, Gao L, Wei X, Zhang Z, Zheng D, Zhang D, Zhang X, Li Y, Zhang Q. Lou H, et al. Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):319-25. doi: 10.1016/j.colsurfb.2011.05.037. Epub 2011 May 27. Colloids Surf B Biointerfaces. 2011. PMID: 21676599 - Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S, Chen T, Chen R, Hu Y, Chen M, Wang Y. Wang S, et al. Int J Pharm. 2012 Jul 1;430(1-2):238-46. doi: 10.1016/j.ijpharm.2012.03.027. Epub 2012 Mar 23. Int J Pharm. 2012. PMID: 22465546 - In vitro and in vivo antitumor activity of oridonin nanosuspension.
Lou H, Zhang X, Gao L, Feng F, Wang J, Wei X, Yu Z, Zhang D, Zhang Q. Lou H, et al. Int J Pharm. 2009 Sep 8;379(1):181-6. doi: 10.1016/j.ijpharm.2009.06.022. Epub 2009 Jun 27. Int J Pharm. 2009. PMID: 19563872 - In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery.
Smitha KT, Anitha A, Furuike T, Tamura H, Nair SV, Jayakumar R. Smitha KT, et al. Colloids Surf B Biointerfaces. 2013 Apr 1;104:245-53. doi: 10.1016/j.colsurfb.2012.11.031. Epub 2012 Dec 20. Colloids Surf B Biointerfaces. 2013. PMID: 23337120
Cited by
- Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique.
Li S, Zhang J, Fang Y, Yi J, Lu Z, Chen Y, Guo B. Li S, et al. Drug Des Devel Ther. 2020 Jan 16;14:243-256. doi: 10.2147/DDDT.S233851. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32021108 Free PMC article. - Anti-inflammatory Effect and Toxicology Analysis of Oral Delivery Quercetin Nanosized Emulsion in Rats.
Hädrich G, Vaz GR, Maidana M, Kratz JM, Loch-Neckel G, Favarin DC, Rogerio Ade P, da Silva FM Jr, Muccillo-Baisch AL, Dora CL. Hädrich G, et al. Pharm Res. 2016 Apr;33(4):983-93. doi: 10.1007/s11095-015-1844-6. Epub 2015 Dec 18. Pharm Res. 2016. PMID: 26687116 - Puerarin inhibits EMT induced by oxaliplatin via targeting carbonic anhydrase XII.
Chen X, Zhou Z, Zhang Z, Zhao C, Li J, Jiang J, Huang B, Qin Y. Chen X, et al. Front Pharmacol. 2022 Aug 25;13:969422. doi: 10.3389/fphar.2022.969422. eCollection 2022. Front Pharmacol. 2022. PMID: 36091779 Free PMC article. - Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
Shao Z, Shao J, Tan B, Guan S, Liu Z, Zhao Z, He F, Zhao J. Shao Z, et al. Int J Nanomedicine. 2015 Feb 11;10:1223-33. doi: 10.2147/IJN.S77837. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25709444 Free PMC article. - Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways.
Xiao L, Zhong M, Huang Y, Zhu J, Tang W, Li D, Shi J, Lu A, Yang H, Geng D, Li H, Wang Z. Xiao L, et al. Aging (Albany NY). 2020 Nov 7;12(21):21706-21729. doi: 10.18632/aging.103976. Epub 2020 Nov 7. Aging (Albany NY). 2020. PMID: 33176281 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous